Here’s What Experts Say You Need If You’re On A GLP-1
It’s no secret that the use of GLP-1 antagonists like Ozempic and Wegovy is more widespread than ever.…
GLP-1 drugs can ‘reverse biologic aging’ by two to three years
Weight loss drugs may do more than melt away pounds — they could melt away years. Pharmaceutical companies…
Biological age test to steer GLP-1 prescriptions
Deep Longevity’s new US telehealth platform, Accrua, ties treatment plans to a blood-based aging score and re-tests every…
GLP-1s linked to a gross side effect in nails: study
Ozempic and Mounjaro can cost an arm and a leg — and maybe a fingernail. A new study…
Can GLP-1 drugs help stop compulsive shopping, gambling and other ways people throw away their money?
A growing body of research suggests GLP-1 drugs can do more than just help people lose weight by…
Weight-loss drug use surges as lawsuits and side-effect concerns grow
LAS VEGAS (FOX5) — New Gallup data shows 11% of U.S. adults are taking weight loss drugs such…
Lilly and Novo share GLP-1 longevity data
Pharma has the podium as Novo and Lilly stop talking about GLP-1 longevity and start measuring it, bringing…
Study finds sharp increase in GLP-1 use among children ages 8 to 11
While it is still relatively rare for young children to be prescribed GLP-1 medications, researchers say their use…
Ozempic Rival Retatrutide Delivers 25% Weight Loss In Phase 3 Trial
An experimental weight-loss injection has helped people with obesity lose an average of up to 25 per cent…
GLP-1 use skyrocketed 24x in a key demographic
This year, the number of US adults on a GLP-1 medication for weight loss reached an astonishing 11%…
New weight-loss drug targets belly fat and can give ‘flatter stomach’ in weeks
Could a new drug that makes fat cells self-destruct be the next big GLP-1? CBL-514 targets fat cells,…
#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy – Endpoints News
#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy Endpoints NewsTrevogrumab cuts semaglutide-induced lean mass loss by…